BIO Seeks Long-Term Government Contracts For Biowarfare R&D
Executive Summary
The Biotechnology Industry Organization is seeking a long-term financial commitment from the government for research and development of agents needed in the event of a bioterrorist attack.
You may also be interested in...
Merck Considers Smallpox Vaccine; Four Companies In Discussions With HHS
Merck is among the companies involved in discussions with HHS regarding manufacture of smallpox vaccine.
Military Vaccine Approvals Based On Animal Studies Could Be Allowed By FDA
Animal efficacy studies could support approval of new products to reduce or prevent the toxicity of chemical, biological, radiological or nuclear substances when efficacy cannot ethically be tested in humans, FDA proposed in a recent Federal Register notice.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011